Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 27-Feb-24 7:29 PM View:  | Tenaya Therapeutics, Inc. (TNYA) | 23-Feb-24 | Grant | 35,000 | -- | -- | 58% 60.76K to 95.75K | |
| 16-Feb-24 8:32 PM View: | Tenaya Therapeutics, Inc. (TNYA) | 16-Feb-24 | Sale | 5,201 | $5.86 | $30,477.90 | (8%) 65.96K to 60.76K | |
| 18-Aug-23 6:31 PM View: | Tenaya Therapeutics, Inc. (TNYA) | 16-Aug-23 | Sale | 4,452 | $3.81 | $16,962.10 | (6%) 68.99K to 64.54K | |
| 17-Feb-23 6:45 PM View: | Tenaya Therapeutics, Inc. (TNYA) | 15-Feb-23 | Grant | 65,000 | -- | -- | 3250% 2.0K to 67.0K | |
| 11-Feb-21 7:47 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 09-Feb-21 | Market Sale | 12,533 | $14.10 | $176,718.00 | (11%) 110.49K to 97.95K | 2% |
| 17-Jun-20 5:47 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 16-Jun-20 | Market Sale | 13,171 | $24.68 | $325,060.00 | (11%) 123.66K to 110.49K | 48% |
| 08-May-20 6:25 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 06-May-20 | Option Exercise | 20,000 | $3.44 | $68,800.00 | 16% 123.66K to 143.66K | |
| 08-May-20 6:25 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 06-May-20 | Market Option Sale (Planned) | 20,000 | $20.02 | $400,400.00 | (14%) 143.66K to 123.66K | 36% |
| 25-Mar-20 5:28 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 20-Mar-20 | Option Exercise | 24,424 | $3.44 | $84,018.60 | 18% 138.53K to 162.96K | |
| 25-Mar-20 5:28 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 20-Mar-20 | Market Option Sale (Planned) | 24,424 | $10.17 | $248,348.00 | (15%) 162.96K to 138.53K | (27%) |
| 25-Mar-20 5:28 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 20-Mar-20 | Market Sale (Planned) | 15,102 | $10.17 | $153,560.00 | (11%) 138.53K to 123.43K | (27%) |
| 18-Mar-20 7:33 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 17-Mar-20 | Market Sale (Planned) | 474 | $10.02 | $4,749.24 | (< 1%) 139.0K to 138.53K | (29%) |
| 10-Feb-20 7:56 AM View: | Adverum Biotechnologies, Inc. (ADVM) | 09-Feb-20 | Payment of Exercise | 11,215 | $10.24 | $114,842.00 | (7%) 150.22K to 139.0K | (26%) |
| 26-Dec-19 4:47 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 23-Dec-19 | Market Sale (Planned) | 40,000 | $10.72 | $428,800.00 | (15%) 268.5K to 228.5K | (20%) |
| 10-Feb-20 7:51 AM View: | Adverum Biotechnologies, Inc. (ADVM) | 15-Jun-19 | Payment of Exercise | 43,852 | $10.82 | $474,479.00 | (19%) 234.07K to 190.22K | (20%) |
| 10-Feb-20 7:51 AM View: | Adverum Biotechnologies, Inc. (ADVM) | 09-Feb-19 | Payment of Exercise | 8,176 | $3.33 | $27,226.10 | (3%) 242.25K to 234.07K | (289%) |
| 18-Jun-18 4:37 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 15-Jun-18 | Grant | 88,496 | -- | -- | 49% 180.0K to 268.5K | |
| 10-Feb-20 7:51 AM View: | Adverum Biotechnologies, Inc. (ADVM) | 15-Jun-18 | Payment of Exercise | 8,645 | $5.55 | $47,979.80 | (3%) 250.89K to 242.25K | (134%) |
| 10-Feb-20 7:51 AM View: | Adverum Biotechnologies, Inc. (ADVM) | 09-Feb-18 | Payment of Exercise | 8,208 | $7.05 | $57,866.40 | (5%) 170.6K to 162.4K | (84%) |
| 10-Feb-20 7:51 AM View: | Adverum Biotechnologies, Inc. (ADVM) | 15-Jun-17 | Payment of Exercise | 9,395 | $2.70 | $25,366.50 | (5%) 180.0K to 170.6K | (381%) |
| 13-Feb-17 5:43 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 09-Feb-17 | Grant | 80,000 | -- | -- | 80% 100.0K to 180.0K | |
| 16-Jun-16 7:26 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 15-Jun-16 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 30-Oct-14 6:50 PM View: | Novacea, Inc. (PRTK) | 30-Oct-14 | Grant | 4,161 | $21.59 | $89,827.70 | 100% 0 to 4.16K | |
| 24-Feb-05 8:39 PM View: | Chiron Corp (CHIR) | 22-Feb-05 | Grant | 1,200 | -- | -- | 26% 4.54K to 5.74K | |
| 21-Sep-04 8:41 PM View: | Chiron Corp (CHIR) | 20-Sep-04 | Market Sale | 1,022 | $45.73 | $46,736.80 | (20%) 5.22K to 4.2K | |
| 01-Sep-04 7:38 PM View: | Chiron Corp (CHIR) | 31-Aug-04 | Payment of Exercise | 108 | $42.16 | $4,553.28 | (2%) 5.33K to 5.22K | |
| 01-Sep-04 7:38 PM View: | Chiron Corp (CHIR) | 30-Aug-04 | Payment of Exercise | 72 | $42.75 | $3,078.00 | (1%) 5.4K to 5.33K | |
| 17-Feb-04 10:00 PM View: | Chiron Corp (CHIR) | 13-Feb-04 | Grant | 1,200 | -- | -- | 27% 4.36K to 5.56K | |
| 02-Jan-04 10:00 PM View: | Chiron Corp (CHIR) | 31-Dec-03 | Payment of Exercise | 108 | $56.66 | $6,119.28 | (2%) 4.47K to 4.36K | |
| 16-Sep-03 10:00 PM View: | Chiron Corp (CHIR) | 15-Sep-03 | Option Exercise | 2,917 | $30.67 | $89,473.20 | 123% 2.37K to 5.29K | |
| 16-Sep-03 10:00 PM View: | Chiron Corp (CHIR) | 15-Sep-03 | Option Sale | 2,917 | $55.80 | $162,779.00 | (55%) 5.29K to 2.37K | |
| 16-Sep-03 10:00 PM View: | Chiron Corp (CHIR) | 15-Sep-03 | Sale | 388 | $55.80 | $21,651.70 | (16%) 2.37K to 1.99K | |
| 12-Sep-03 10:00 PM View: | Chiron Corp (CHIR) | 31-Aug-03 | Payment of Exercise | 180 | $50.54 | $9,097.20 | (7%) 2.55K to 2.37K |